Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 2/20 | 0.49 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.49 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29862920 | 1.00 | PIK3CD (0.54) | PIK3CDCYP11B2PDE4APDE4BPDE4C | |
| SCHEMBL5461785 | 0.87 | KDM1A (0.54) | PIK3CDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL29862682 | 0.87 | KDM1A (0.54) | PIK3CDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5454387 | 0.86 | GPR119 (0.57) | PDE4APDE4BPDE4CPDE4DKDM1A | |
| SCHEMBL30481315 | 0.85 | PDE4B (0.48) | PIK3CDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL25256501 | 0.85 | PDE4B (0.48) | PIK3CDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7965544 | 0.82 | CYP11B2 (0.55) | PIK3CDCYP11B2GPR119 | |
| SCHEMBL5665583 | 0.82 | KDM1A (0.51) | PIK3CDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23359680 | 0.81 | CYP11B2 (0.53) | PIK3CDCYP11B2GPR119 | |
| SCHEMBL29862495 | 0.81 | CYP11B2 (0.53) | PIK3CDCYP11B2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4055014-B1 | PYRROLIDINE AND PIPERIDINE COMPOUNDS | YUHAN CORP (KR) | 2025-04-30 | — | — | EP | disclosed |
| US-11655235-B2 | Pyrrolidine and piperidine compounds | YUHAN CORPORATION (KR) | 2023-05-23 | — | — | US | disclosed |
| EP-4055014-A1 | PYRROLIDINE AND PIPERIDINE COMPOUNDS | Yuhan Corporation (KR) | 2022-09-14 | — | — | EP | disclosed |
| CN-114867719-A | Pyrrolidine and piperidine compounds | 柳韩洋行 | 2022-08-05 | — | — | CN | disclosed |
| US-20210147386-A1 | PYRROLIDINE AND PIPERIDINE COMPOUNDS | YUHAN CORPORATION (KR) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655235-B2 | Pyrrolidine and piperidine compounds | FAP, APC, VHL | PIK3CD 641/4885CYP11B2 4535/4885PDE4A 216/4885 |
| US-20210147386-A1 | PYRROLIDINE AND PIPERIDINE COMPOUNDS | FAP, APC, VHL | PIK3CD 641/4885CYP11B2 4535/4885PDE4A 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.